Guertin J, LeLorier J, Durand M, Gow R, Holbrook A, Levine M. IMPACT OF A RESTRICTIVE DRUG ACCESS PROGRAM ON THE RISK OF CARDIOVASCULAR ENCOUNTERS IN CHILDREN EXPOSED TO ADHD MEDICATIONS. J Popl Ther Clin Pharmacol [Internet]. 2018 Nov. 12 [cited 2024 Nov. 19];21(3). Available from: https://mail.jptcp.com/index.php/jptcp/article/view/302